CompanyUnited StatesUpdated May 6, 2026
NVIDIA’s NVentures

NVIDIA’s NVentures

NVIDIA’s NVentures: Investor, Venture Capital • focus on Venture Capital • active in North America, Europe • offices in United States, Sweden.

Never miss breaking news

Get instant notifications when new news matching "NVIDIA’s NVentures" are published.

Company Profile

NVentures is the corporate venture capital arm of NVIDIA, established in 2021 to strategically invest in early-stage technology companies. The firm's core mission is to partner with visionary founders who are leveraging NVIDIA's hardware and AI-driven innovation to address complex challenges across a multitude of sectors. NVentures aims to generate strong financial returns while simultaneously expanding the broader NVIDIA ecosystem by supporting companies that are deeply relevant to NVIDIA's platforms and technologies.

The venture unit formally emerged in early 2023, though its head, Mohamed Siddeek, rejoined NVIDIA in 2021 to form NVentures, bringing extensive experience from top-tier investment firms like SoftBank's Vision Fund, KKR, and Morgan Stanley. This background, combined with other key team members' long-standing leadership roles within NVIDIA's business development, provides a blend of financial acumen and strategic technology insight. NVentures' investment strategy is distinct from NVIDIA's larger corporate investments, focusing on enhancing the platforms of its portfolio companies through NVIDIA's technical expertise and go-to-market excellence.

NVentures has made numerous notable investments across the AI ecosystem. Recent portfolio companies include Legora, a Swedish AI legal tech startup, and Aidoc, an Israeli clinical AI company. The firm has also backed companies like Seurat Technologies and Machina Labs, which are disrupting industrial processes and advanced manufacturing. Other significant investments span areas such as quantum computing (Quantinuum), generative AI (Mistral AI, OpenAI, Cohere, Hugging Face, Inflection), autonomous driving (Wayve), robotics (Figure AI, Skild AI, Dyna Robotics, Generalist AI), and AI infrastructure (Scale AI, CoreWeave, Nscale, Nebius). The portfolio also includes companies in biotech and drug discovery (Genesis Therapeutics, Inceptive, Terray, Charm, Evozyne, Generate, Superluminal, Abridge Inc), and various software and developer tools (Synthesia, n8n, CodeRabbit, Imbue, Unstructured).

The firm's investment thesis is broad, encompassing any area where NVIDIA's technology can make a significant impact, from healthcare and manufacturing to financial services and beyond. NVentures actively seeks to support companies that are building the future of AI, offering not just capital but also unique access to NVIDIA's technology, expertise, and global ecosystem to accelerate their growth. This approach positions NVentures as a crucial player in shaping the AI-first economy.

News & Signals (0)

No linked news activity found for this company.

Investor Listings

Similar Companies

Ranked by shared taxonomies: sector, subsector, geography, asset class and investor lists.

No similar companies found with overlapping taxonomy tags.